Responses to NMDA Receptor Antagonists Altered by Epileptogenesis
Overview
Affiliations
Barker-Haliski M, White H Neuropharmacology. 2019; 167:107750.
PMID: 31469995 PMC: 7470169. DOI: 10.1016/j.neuropharm.2019.107750.
Loscher W Neurochem Res. 2017; 42(7):1873-1888.
PMID: 28290134 DOI: 10.1007/s11064-017-2222-z.
Loscher W Neurochem Res. 2016; 42(7):1926-1938.
PMID: 27502939 DOI: 10.1007/s11064-016-2025-7.
New avenues for anti-epileptic drug discovery and development.
Loscher W, Klitgaard H, Twyman R, Schmidt D Nat Rev Drug Discov. 2013; 12(10):757-76.
PMID: 24052047 DOI: 10.1038/nrd4126.
The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.
Boehlen A, Schwake M, Dost R, Kunert A, Fidzinski P, Heinemann U Br J Pharmacol. 2012; 168(5):1182-200.
PMID: 23176257 PMC: 3594676. DOI: 10.1111/bph.12065.